Development of CD388 as a long-lasting prophylactic anti-viral option for protection against the health impacts caused by influenza

Award NoticeNo Set AsideAwarded

This federal contract opportunity has been awarded to on September 30, 2025.

Award Information

This solicitation resulted in an award to for approximately $339,189,481 on September 30, 2025. Similar contracts are typically issued by HEALTH AND HUMAN SERVICES, DEPARTMENT OF under 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Award Number
75A50125C00017
Award Amount
$339,189,481
Award Date
September 30, 2025

Key Takeaways

Contract Details

Notice ID
75A50125C00017
Opportunity Type
Award Notice
Sub-Agency
OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office
BARDA - ASPR / DAAPPO / BARDA DCMA
Posted Date
Tuesday, October 14, 2025
Response Deadline
Not specified
PSC Code
AN13
Set-Aside
No Set Aside
Place of Performance
WASHINGTON, DC, 20515
Status
Active

Description

No description available. View the full opportunity on SAM.gov for complete details.

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for research and development in biotechnology (except nanobiotechnology) with a set-aside for No Set Aside businesses in WASHINGTON, DC. This set-aside designation means eligible businesses face reduced competition from larger firms.

Similar Opportunities

Browse Related

Looking for more opportunities?

Browse our full directory of government contracts

View All Contracts